混血穴位注射疗法治疗慢性乙型肝炎54例

Acupoint-injection with Blending Blood and Anti-HB-IRNA in Treatment of Chronic Hepatitis B-An Observation on 54 Cases

目的:探讨混血穴位注射治疗慢性乙型肝炎的效果。方法:采用抗乙肝免疫核糖核酸混合患者静脉血,作穴住注射(混血穴位注射),疗程6个月,并与对照1组(自血穴位注射)及2组(单纯注射抗乙肝免疫核糖核酸)进行比较。结果:3组患者治疗前后自身对照ALT、AST的差异有显著性意义(P<0.01)、治疗组治疗后与两对照组比较差异也有显著性意义(P<0.05);对HBV-M、HBV DNA的抑制,治疗组明显优于对照组,差异有显著性意义(P<0.01)。结论:混血穴位注射可提高慢性乙型肝炎的治疗效果。

Objective: To study the efficacy of acupoint-injection with blending blood and anti-HB-IRNA in treatment of chronic hepatitis B. Methods: Acupoint-injection with blending blood and anti-HB-IRNA (treatment group) was used in treatment of 54 cases of Chronic hepatitis B patients for 6 months, and compared with 42 patients using acupoint-injection with self-blood, and 40 patients using anti-HB-IRNA alone for muscular injection. Results: There were significant differences (P< 0.01) in terms of improvement of ALT and AST before and after treatment in three groups; The improvement of ALT and AST in treatment group was significantly superior to the controls (P<0.05); The inhibitory effect of HBV-M and HBV-DNA in treatment group was significantly superior to that of the controls (P<0.01); while there was no significant difference between the two controls (P>0.05). Conclusion: Acupoint-injection with blending blood and anti-HB-IRNA can improve the therapeutic efficacy of either acupoint-injection with self-blood or anti-HB-IRNA for muscular injection.